Key Highlights
- UNH touched a 52-week peak of $404.14 this Wednesday, climbing approximately 30% in the last month
- First-quarter revenue reached $111.7 billion, reflecting a 2% annual increase, while adjusted EPS exceeded forecasts at $7.23
- Operating margins at UnitedHealthcare expanded from 6.2% to 6.6% during Q1
- The company’s Medical Care Ratio decreased to 83.9% in Q1, compared to 88.9% in the previous quarter
- Strategic reduction of 1.3 million Medicare Advantage enrollees in 2026 aims to preserve profitability
UnitedHealth Group (UNH) reached a 52-week peak of $404.14 during Wednesday’s trading session, marking the culmination of an impressive rally that has propelled shares approximately 30% higher over the past thirty days.
UnitedHealth Group Incorporated, UNH
Since the start of this year, UNH has appreciated roughly 21%. Looking at the trailing twelve-month period, the healthcare giant has delivered gains of approximately 29%.
This upward momentum comes after a challenging opening to the year. Between January and late March, shares tumbled from $336 down to $259 — representing a decline of roughly 23%.
The rebound took hold after UnitedHealth delivered Q1 financial results in late April that surpassed Wall Street’s expectations and featured upgraded forward guidance.
First-quarter revenue reached $111.7 billion, marking a 2% year-over-year increase. Adjusted earnings per share landed at $7.23, exceeding analyst projections. Reported EPS stood at $6.90.
UnitedHealthcare’s operating margins expanded from 6.2% to 6.6%, representing a modest yet significant enhancement for an organization navigating a transitional phase.
Medicare Advantage Continues to Present Challenges
Medicare Advantage has emerged as one of the most prominent headwinds facing UNH. Federal reimbursement rates have failed to match the pace of escalating program expenses, compressing margins in recent years.
To address this dynamic, UnitedHealth strategically reduced its Medicare Advantage enrollment by 1.3 million individuals for 2026. While difficult, leadership positioned this decision as essential for maintaining long-term financial health.
The financial data reflects these adjustments. UnitedHealth’s Medical Care Ratio — representing the proportion of premium revenue allocated to medical claims — declined to 83.9% in Q1, down sharply from 88.9% in Q4 2025.
This substantial quarter-over-quarter improvement indicates that the enrollment reductions are already influencing the company’s cost dynamics positively.
The Year Started on a Challenging Note
Early 2025 proved turbulent for the stock. UnitedHealth experienced a significant selloff in January following disappointing Q4 2024 results and after CMS announced Medicare Advantage reimbursement rate proposals that fell short of market expectations.
The organization has also navigated leadership transitions and faces an ongoing antitrust examination. While these concerns persist, market participants currently seem focused on the operational improvements.
At the current valuation near $400, UNH offers a dividend yield of approximately 2.3%, supported by a market capitalization of roughly $360 billion.
The stock’s 52-week trading range extends from $234.60 to $404.15 — with Wednesday’s high matching the upper boundary.
Wednesday’s trading volume registered around 4.8 million shares, below the typical daily average of 8.5 million, indicating the advance occurred without exceptionally heavy activity.
UNH last changed hands at $400.38 based on the most recent Wednesday pricing data.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
